Author: Dorron Blumberg

December 3, 2019 — Florida Cancer Specialists & Research Institute (FCS) is pleased to announce the addition of Shekeab Jauhari, MD as a principal investigator on its research team. Dr. Jauhari is a medical oncologist/hematologist who will be leading Phase 1 clinical trials at the newest FCS Drug Development Unit in Lake Mary, FL, which is part of Sarah Cannon Research Institute (Sarah Cannon) and scheduled to open in early 2020. As a strategic research site for Sarah Cannon, one of the leading clinical research organizations in the world, FCS conducts clinical trials at more than 36 locations throughout the state.

December 3 2019 – With increasing demand to help underserved populations gain access to quality healthcare, FoundCare, Inc. celebrated its most recent expansion with a ribbon cutting ceremony for its pediatric office at FoundCare Pediatric North. Three experienced physicians oversee the approximately 4,500 square foot space located in the Mollie Wilmot Palm Healthcare Pavilion at 5205 Greenwood Avenue in West Palm Beach. 

December 2, 2019 – Scientists from around the world participated in the Cleveland Clinic Florida Research and Innovation Symposium hosted on Nov. 21 and 22. The symposium was a collaborative effort between Cleveland Clinic Florida, the Cleveland Clinic Lerner Research Institute, Florida International University and Vaxine Pty Ltd, an Australian biotechnology company focusing on development of innovative vaccine technologies.

December 2 2019 – NSU Board of Trustee member, Zachariah P. Zachariah, M.D., was appointed to the National Institutes of Health’s National Heart, Lung and Blood Advisory Council,  NSU President Dr. George Hanbury announced today. The appointment was made by Alex Azar, the U.S. Secretary of Health and Human Services.